The main objective of this project Is to determine the clinical outcomes and their association with parasite and host features of malaria-infected individuals living In non-Amazon regions of Latin America (LA) with different intensities of malaria transmission. It is hypothesized that clinical manifestations of malaria in infected individuals living in high malaria transmission areas are different from those observed in low transmission areas in which both parasites P. vivax and P. falciparum co-exist. These studies will be conducted through the following specific alms: 1) establishment of the clinical profile of malaria In different epidemiological settings and their association with parasite and host immunological status:;2) assess the prevalence of malaria mixed infections and its influence in the clinical outcomes of the disease;3) determine the prevalence of hematological manifestations related to malaria infection and their association with concomitant immune status nutritional factors, and helminth co-infections, and 4) determine the prevalence of placental malaria and Its impact on neonatal health and child development. This is a multisite center study in Latin America in which cross-sectional, cohort studies and longitudinal and cohort studies will be performed In 3,600 individuals for alms 1-3 and 200 newborns for aim 4. Parasitological, hematological, and immunological evaluations will be performed and concomitant non-malaria infections will be evaluated. The impact of malaria on child growth and development and level of impairment will be assessed using locally standardized questionnaires based on International guidelines (BMI and ICF). The overall studies proposed in this project will not only provide a better understanding ofthe immunopathogenesis of malaria in LA but will also generate useful Information for malaria case management, control strategies including antimalaria therapy, future use of malaria vaccine and points of intervention to improve developmental outcomes of children living in malaria endemic regions of LA.

Public Health Relevance

Coordinated multi-site studies on malaria immunopathogenesis will be conducted in three countries of Latin America. This will be the first large-scale comprehensive study on malaria Immunopatogenesis of malaria in low-to-moderate malaria endemic regions of Latin America.

Agency
National Institute of Health (NIH)
Type
Research Program--Cooperative Agreements (U19)
Project #
5U19AI089702-05
Application #
8711220
Study Section
Special Emphasis Panel (ZAI1)
Project Start
Project End
Budget Start
Budget End
Support Year
5
Fiscal Year
2014
Total Cost
Indirect Cost
Name
Caucaseco Scientific Research Center
Department
Type
DUNS #
City
Cali
State
Country
Colombia
Zip Code
Forero, David A; Chaparro, Pablo E; Vallejo, Andres F et al. (2014) Knowledge, attitudes and practices of malaria in Colombia. Malar J 13:165
Fuller, D O; Troyo, A; Alimi, T O et al. (2014) Participatory Risk Mapping of Malaria Vector Exposure in Northern South America using Environmental and Population Data. Appl Geogr 48:1-7
Schneider, Kristan A; Escalante, Ananias A (2014) A likelihood approach to estimate the number of co-infections. PLoS One 9:e97899
Kim, Yuseob; Escalante, Ananias A; Schneider, Kristan A (2014) A population genetic model for the initial spread of partially resistant malaria parasites under anti-malarial combination therapy and weak intrahost competition. PLoS One 9:e101601
Herrera, Sócrates; Vallejo, Andrés F; Quintero, Juan P et al. (2014) Field evaluation of an automated RDT reader and data management device for Plasmodium falciparum/Plasmodium vivax malaria in endemic areas of Colombia. Malar J 13:87
Naranjo, Diana P; Qualls, Whitney A; Jurado, Hugo et al. (2014) Vector control programs in Saint Johns County, Florida and Guayas, Ecuador: successes and barriers to integrated vector management. BMC Public Health 14:674
Céspedes, Nora; Jiménez, Eliécer; Lopez-Perez, Mary et al. (2014) Antigenicity and immunogenicity of a novel Plasmodium vivax circumsporozoite derived synthetic vaccine construct. Vaccine 32:3179-86
Chamchod, Farida; Beier, John C (2013) Modeling Plasmodium vivax: relapses, treatment, seasonality, and G6PD deficiency. J Theor Biol 316:25-34
Taylor, Jesse E; Pacheco, M Andreina; Bacon, David J et al. (2013) The evolutionary history of Plasmodium vivax as inferred from mitochondrial genomes: parasite genetic diversity in the Americas. Mol Biol Evol 30:2050-64
Rice, Benjamin L; Acosta, Monica M; Pacheco, Maria Andreina et al. (2013) Merozoite surface protein-3 alpha as a genetic marker for epidemiologic studies in Plasmodium vivax: a cautionary note. Malar J 12:288

Showing the most recent 10 out of 23 publications